Q1 2020 Novocure Ltd Earnings Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the NovoCure First Quarter 2020 Earnings Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded. (Operator Instructions).
I would now like to hand the conference to your speaker today, Ashley Cordova, Senior Vice President of Finance and Investor Relations. Please go ahead, ma'am.
Good morning, everyone, and thank you for joining us to review NovoCure's first quarter 2020 performance. On behalf of the entire NovoCure team, we would like to begin by wishing you well as we collectively face the challenges of the COVID-19 pandemic. We hope that you and your loved ones are staying healthy and safe during this unprecedented time.
With safety in mind, we are conducting today's call virtually. I am joined on the phone by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Wilco Groenhuysen. Pritesh Shah, our Chief Commercial Officer; and Ely Benaim, our Chief
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |